Kihaa Laboratories (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -69.26%
- Profit Growth -77.52%
- Ebitda -70.21%
- Net Worth 21.98%
- Total Assets 47.42%
About Kihaa Laboratories (Opc)
Kihaa Laboratories (Opc) Private Limited (KLOPL) is a Company incorporated in India on 24 September 2021 (Three years and four months 17 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitesh Agrawal serves as a director at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24297RJ2021OPC077170
-
Company No.
077170
-
Incorporation Date
24 Sep 2021
-
Date of AGM
-
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Kihaa Laboratories (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitesh Agrawal
|
Director | 24-Sep-2021 | Current |
Financial Performance of Kihaa Laboratories (Opc).
Kihaa Laboratories (Opc) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 69.26% decrease. The company also saw a substantial fall in profitability, with a 77.52% decrease in profit. The company's net worth Soared by an impressive increase of 21.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kihaa Laboratories (Opc)?
Unlock access to Kihaa Laboratories (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Wriver Life Sciences Private LimitedNitesh Agrawal is a mutual person
-
Mediclus Lifesciences Private Limited
Nitesh Agrawal is a mutual person
-
Kihaa Foods And Hospitality Private Limited
Nitesh Agrawal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kihaa Laboratories (Opc)?
Kihaa Laboratories (Opc) has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kihaa Laboratories (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kihaa Laboratories (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.